Spectral Medical Stock Quote EDT - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

0.485

Bid

0.48

Ask

0.52

Volume

15,186

0.47 Day's Range 0.49

0.225 52 Week Range 0.67

Market Cap

133.716M

Previous Close

0.49

Open

0.49

Last Trade

3000

0.485

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

60,396

Shares Outstanding

278,576,000

Dividend Yield

PE Ratio

-8.54

Earnings Per Share (EPS)

-0.06

Revenue

1.6M

Net Profit

-15.66M

Sector

In Vitro,in Vivo Diagnostics

Industry

Testing Laboratories

Website

www.spectraldx.com

Headquarters

Toronto, Ontario, Can

Founded

1991

Spectral Medical Inc is listed in the In Vitro,in Vivo Diagnostics sector of the Toronto Stock Exchange with ticker EDT. The last closing price for Spectral Medical was $0.49. Over the last year, Spectral Medical shares have traded in a share price range of $ 0.225 to $ 0.67.

Spectral Medical currently has 278,576,000 shares outstanding. The market capitalization of Spectral Medical is $133.72 million. Spectral Medical has a price to earnings ratio (PE ratio) of -8.54.

Spectral Medical Announces First Quarter Results and Provides Corporate Update

Tigris Trial Enrollment Reaches 106 Patients Bought Deal Financing Expected to Fund Completion of Tigris Trial Enrollment TORONTO, May 13, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc...

Spectral Medical Inc. Announces C$8.5 Million Bought Deal Convertible Note Financing

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES OF AMERICA OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES OF AMERICA, ITS TERRITORIES AND POSSESSIONS, ANY...

Spectral Medical Provides April Tigris Trial Update

• 105 patients enrolled • April represents a record breaking month for patient enrollment TORONTO, May 06, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”...

Spectral Medical Chair to Retire From the Board of Directors

TORONTO, April 02, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic...

Spectral Medical Announces Fourth Quarter and Fiscal 2023 Results and Provides Corporate Update

TORONTO, March 28, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic...

Spectral Medical Provides February Tigris Trial Update

93 patients enrolledFebruary represents a second record breaking consecutive month for patient enrollment TORONTO, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the...

Spectral Medical Announces Amendment and Extension of Exclusive Supply and Distribution Agreement With Baxter Healthcare Corporation

TORONTO, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic...

Spectral Medical Announces Major Milestone by Reaching Its Interim Enrollment Target of 90 Patients

TORONTO, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic...

Spectral Medical Provides Early February Tigris Trial Update

88 patients enrolled January being the highest enrollment month since the launch of Tigris TORONTO, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX:...

Spectral Medical Provides January Tigris Trial Update

TORONTO, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic...